Junqing Gan

587 total citations
13 papers, 390 citations indexed

About

Junqing Gan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Junqing Gan has authored 13 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Junqing Gan's work include RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Ferroptosis and cancer prognosis (3 papers). Junqing Gan is often cited by papers focused on RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Ferroptosis and cancer prognosis (3 papers). Junqing Gan collaborates with scholars based in China and Türkiye. Junqing Gan's co-authors include Mingxia Jiang, Yiming Wu, Ling Qi, Dongfeng Song, Yuxian Bai, Yanjing Li, Lisha Li, Lisha Li, Yanjing Li and Qingwei Meng and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Pharmacology and Cancer Letters.

In The Last Decade

Junqing Gan

10 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junqing Gan China 9 304 128 103 85 60 13 390
Xiangyu Qiu China 5 325 1.1× 146 1.1× 126 1.2× 108 1.3× 14 0.2× 8 396
Xiangming Yan China 11 209 0.7× 58 0.5× 94 0.9× 35 0.4× 19 0.3× 21 356
Kui Cao China 10 223 0.7× 99 0.8× 103 1.0× 52 0.6× 33 0.6× 20 306
Zhijun Xu China 11 317 1.0× 117 0.9× 146 1.4× 79 0.9× 50 0.8× 28 558
Lingzhang Meng China 11 181 0.6× 58 0.5× 96 0.9× 83 1.0× 24 0.4× 42 358
Baohong Gu China 11 148 0.5× 128 1.0× 84 0.8× 89 1.0× 44 0.7× 38 387
Sihui Yu China 8 153 0.5× 36 0.3× 81 0.8× 84 1.0× 16 0.3× 12 255
Jiabin Yang China 11 166 0.5× 60 0.5× 104 1.0× 33 0.4× 38 0.6× 31 331
Brittney S. Harrington United States 10 211 0.7× 37 0.3× 87 0.8× 56 0.7× 9 0.1× 19 393
Yunlim Kim South Korea 12 193 0.6× 98 0.8× 93 0.9× 25 0.3× 24 0.4× 24 334

Countries citing papers authored by Junqing Gan

Since Specialization
Citations

This map shows the geographic impact of Junqing Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junqing Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junqing Gan more than expected).

Fields of papers citing papers by Junqing Gan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junqing Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junqing Gan. The network helps show where Junqing Gan may publish in the future.

Co-authorship network of co-authors of Junqing Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Junqing Gan. A scholar is included among the top collaborators of Junqing Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junqing Gan. Junqing Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Qi, Lishuang, Xiaoyi Huang, Xiao Feng, et al.. (2024). RHBDF1 modulates cisplatin sensitivity of small cell lung cancer through YAP1/Smad2 signaling pathway. Heliyon. 10(13). e33454–e33454.
3.
Yao, Yihan, et al.. (2024). [Isoliquiritigenin Modulates the Effect of LINC01503 
on Lung Squamous Carcinoma Cells].. SHILAP Revista de lepidopterología. 27(8). 565–578.
4.
Gan, Junqing, Shan Liu, Juan Zhao, et al.. (2023). MicroRNA-375 restrains the progression of lung squamous cell carcinoma by modulating the ERK pathway via UBE3A-mediated DUSP1 degradation. Cell Death Discovery. 9(1). 199–199. 9 indexed citations
5.
Wang, Lei, et al.. (2022). Characterization of the prognostic and diagnostic values of ALKBH family members in non-small cell lung cancer. Pathology - Research and Practice. 231. 153809–153809. 14 indexed citations
7.
Li, Lisha, Dongfeng Song, Ling Qi, et al.. (2021). Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axis. Cancer Letters. 520. 143–159. 87 indexed citations
8.
Jiang, Mingxia, Yiming Wu, Ling Qi, et al.. (2021). Dihydroartemisinin mediating PKM2-caspase-8/3-GSDME axis for pyroptosis in esophageal squamous cell carcinoma. Chemico-Biological Interactions. 350. 109704–109704. 46 indexed citations
9.
Jiang, Mingxia, Qi Ling, Kexin Jin, et al.. (2021). eEF2K as a novel metastatic and prognostic biomarker in gastric cancer patients. Pathology - Research and Practice. 225. 153568–153568. 9 indexed citations
10.
Li, Lisha, Mingxia Jiang, Ling Qi, et al.. (2021). Pyroptosis, a new bridge to tumor immunity. Cancer Science. 112(10). 3979–3994. 152 indexed citations
11.
Gan, Junqing, Shumin Li, Yu Meng, et al.. (2020). The influence of photodynamic therapy on the Warburg effect in esophageal cancer cells. Lasers in Medical Science. 35(8). 1741–1750. 13 indexed citations
12.
Gan, Junqing, Qingwei Meng, & Yanjing Li. (2020). Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-small-Cell Lung Cancer. Frontiers in Molecular Biosciences. 7. 572406–572406. 15 indexed citations
13.
Li, Shumin, Peng Huang, Junqing Gan, et al.. (2019). Dihydroartemisinin represses esophageal cancer glycolysis by down-regulating pyruvate kinase M2. European Journal of Pharmacology. 854. 232–239. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026